Irina Pestrikova - 18 Jun 2021 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Senior Director, Finance
Signature
/s/ Irina Pestrikova by Mark Busch, attorney-in-fact
Issuer symbol
NDRA
Transactions as of
18 Jun 2021
Net transactions value
$0
Form type
4
Filing time
22 Jun 2021, 16:12:07 UTC
Next filing
30 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NDRA Stock Option Award $0 +75,000 $0.000000 75,000 18 Jun 2021 Common Stock 75,000 $2.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option grant becomes exercisable in three equal annual installments beginning June 18, 2022.